| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 181 | LYSOZYME TRANSGENIC UNGULATES | PCT/US2004000606 | 2004-01-08 | WO2004063349A3 | 2004-11-11 | MURRAY JAMES D; ANDERSON GARY B; MAGA ELIZABETH A |
| The present invention provides transgenic ungulates that include a transgene that encodes lysozyme, and further has an attenuated or non-functional beta-lactoglobulin allele. The invention further provides methods for producing such animals. The invention further provides methods of producing a food product, such as milk, or a milk product, using a subject transgenic ungulate, as well as food products harvested from a subject transgenic ungulate. | ||||||
| 182 | POWDER COMPOSITION FOR THE DISINFECTION OF UNGULATES' BATHS | PCT/EP2012/074464 | 2012-12-05 | WO2013083612A1 | 2013-06-13 | GELMI, Fabio; VENTURINI, Maurizio |
A powder composition for the disinfection of ungulates' baths is disclosed. In particular the present invention relates to the use of a powder composition as a disinfecting agent for the preparation of the baths suitable for ungulates' prophylaxis. It comprises at least one chlorinated organic compound, copper sulphate, EDTA, a natural gum and an inorganic carbonate at specific weight percentages. |
||||||
| 183 | 프리온 단백질 활성이 감소된 트랜스제닉 유제동물 및 그의용도 | KR1020057008140 | 2003-11-10 | KR1020050093761A | 2005-09-23 | 로블,제임스; 구로이와,요시미; 도미즈까,가즈마; 이시다,이사오 |
| The invention provides cloned transgenic ungulates (e.g., bovines) in which prion protein activity is reduced by one or more genetically engineered mutations. Desirably, these transgenic bovines are also genetically modified to express xenogenous (e.g., human) antibodies. Because of their resistance to prion-related diseases such as bovine spongiform encephalopy (also known as mad cow disease), these bovines are a safer source of human antibodies for pharmaceutical uses and safer source of agricultural products. | ||||||
| 184 | SHOE AND SHOEING METHOD | EP01948918.6 | 2001-02-01 | EP1251733B1 | 2004-04-14 | Poynton, Andrew Paul |
| A shoe for a hoofed animal, e.g. a horseshoe, is described which comprises a body made from a thermoplastic composition which comprises a matrix of a thermoplastic material which has a softening point of less than 100 DEG C, such as a polycaprolactone. A method of shoeing a hoofed animal, such as a horse, is also described. | ||||||
| 185 | SHOE AND SHOEING METHOD | EP01948918.6 | 2001-02-01 | EP1251733A1 | 2002-10-30 | Poynton, Andrew Paul |
| A shoe for a hoofed animal, e.g. a horseshoe, is described which comprises a body made from a thermoplastic composition which comprises a matrix of a thermoplastic material which has a softening point of less than 100 °C, such as a polycaprolactone. A method of shoeing a hoofed animal, such as a horse, is also described. | ||||||
| 186 | Vaccines comprising acapsular P. multocida hyaE deletion mutants | US10882666 | 2004-07-02 | US20050106185A1 | 2005-05-19 | Robert Briggs; Fred Tatum |
| Acapsular hyaE deletion mutants of P. multocida can be administered to mammals, particularly ungulates, or birds to provide protective immunity against wild-type P. multocida, e.g., to prevent or reduce the severity of hemorrhagic septicemia or pneumonia in mammals, particularly livestock, ungulates, and companion animals, or fowl cholera in birds, particularly poultry. | ||||||
| 187 | Vaccines comprising acapsular P. multocida hyaE deletion mutants | US10882666 | 2004-07-02 | US07351416B2 | 2008-04-01 | Robert E. Briggs; Fred M. Tatum |
| Acapsular hyaE deletion mutants of P. multocida can be administered to mammals, particularly ungulates, or birds to provide protective immunity against wild-type P. multocida, e.g., to prevent or reduce the severity of hemorrhagic septicemia or pneumonia in mammals, particularly livestock, ungulates, and companion animals, or fowl cholera in birds, particularly poultry. | ||||||
| 188 | 免疫組合物及方法 COMPOSITION AND METHOD FOR IMMUNIZATION | TW097120955 | 2008-06-05 | TW200918552A | 2009-05-01 | 格蘭 湯瑪斯 瑞林 RAWLIN, GRANT THOMAS; 洛伊 邁可 羅冰斯 布朗 ROBINS-BROWNE, ROY MICHAEL; 希爾 羅森布格 ROSENBERG, ZEIL |
| 本發明係有關一種包含多株抗體且用於個體被動免疫對抗EV71之口服製劑組合物;及一種於超免疫有蹄類動物之初乳或者超免疫禽類蛋中產生對抗EV71抗原之多株抗體之方法。 | ||||||
| 189 | ANIMAL REPELLING DEICER | PCT/US2011/056698 | 2011-10-18 | WO2013058738A1 | 2013-04-25 | ROSENBURGH, Neil Alexander; DAUM, Michelle Lee; BAGLEY, Jason Louis; PANNELL, Dan; SHELITE, Kristopher |
Deicing products designed to deter ungulates are provided, along with methods of using those products to treat iced surfaces. The deicing product comprises a mixture of a deicer along with an ungulate repellent. The repellent can repel based on conditioned avoidance, fear, chemical irritation, and/or bad taste. The deicer can be a salt or a deicer solution. The invention is useful for deterring any ungulate that might be attracted to a component of the deicing product (e.g., the salt), but it is particularly useful for deterring deer. |
||||||
| 190 | TRANSGENIC ANIMALS AND USES THEREOF | US13080923 | 2011-04-06 | US20110231943A1 | 2011-09-22 | JAMES M. ROBL; YOSHIMI KUROIWA; POOTHAPPILLAI KASINATHAN; ISAO ISHIDA; KAZUMA TOMIZUKA |
| In general, the invention features genetically modified non-human mammals (e.g., bovines and other ungulates), and methods of making these mammals. In particular, the invention features transgenic ungulates having reduced levels of endogenous IgM heavy chain and/or prion protein. | ||||||
| 191 | Method of producing xenogenous antibodies using a bovine | US12215085 | 2008-06-25 | US07928285B2 | 2011-04-19 | James M. Robl; Yoshimi Kuroiwa; Poothappillai Kasinathan; Isao Ishida; Kazuma Tomizuka |
| In general, the invention features genetically modified non-human mammals (e.g., bovines and other ungulates), and methods of making these mammals. In particular, the invention features transgenic ungulates having reduced levels of endogenous IgM heavy chain and/or prion protein. | ||||||
| 192 | Transgenic animals and uses thereof | US11111310 | 2005-04-21 | US07420099B2 | 2008-09-02 | James M. Robl; Yoshimi Kuroiwa; Poothappillai Kasinathan; Isao Ishida; Kazuma Tomizuka |
| In general, the invention features genetically modified non-human mammals (e.g., bovines and other ungulates), and methods of making these mammals. In particular, the invention features transgenic ungulates having reduced levels of endogenous IgM heavy chain and/or prion protein. | ||||||
| 193 | Transgenic animals and uses thereof | US11111310 | 2005-04-21 | US20060041945A1 | 2006-02-23 | James Robl; Yoshimi Kuroiwa; Poothappillai Kasinathan; Isao Ishida; Kazuma Tomizuka |
| In general, the invention features genetically modified non-human mammals (e.g., bovines and other ungulates), and methods of making these mammals. In particular, the invention features transgenic ungulates having reduced levels of endogenous IgM heavy chain and/or prion protein. | ||||||
| 194 | Transgenic animals and uses thereof | US12215085 | 2008-06-25 | US20090222935A1 | 2009-09-03 | James M. Robl; Yoshimi Kuroiwa; Poothappillai Kasinathan; Isao Ishida; Kazuma Tomizuka |
| In general, the invention features genetically modified non-human mammals (e.g., bovines and other ungulates), and methods of making these mammals. In particular, the invention features transgenic ungulates having reduced levels of endogenous IgM heavy chain and/or prion protein. | ||||||
| 195 | VACCINE AGAINST PAPILLOMATOUS DIGITAL DERMATITIS (PDD) | PCT/US1999/026537 | 1999-11-09 | WO00027429A2 | 2000-05-18 | |
| This invention relates to the diagnosis and prevention of ungulate diseases caused by the spirochete bacteria Treponema. The invention specifically relates to isolated cultures of this spirochete and isolated nucleic acids and proteins. | ||||||
| 196 | EMBRYONIC STEM CELLS FOR MAKING CHIMERIC AND TRANSGENIC UNGULATES | PCT/US1994005529 | 1994-05-16 | WO1994026884A1 | 1994-11-24 | BIOTECHNOLOGY RESEARCH AND DEVELOPMENT CORPORATION; WHEELER, Matthew, B. |
| Transgenic ungulates and compositions and methods for making and using same, are provided. Central to the invention are porcine, bovine, ovine and caprine embryonic stem cell lines and methods for establishing them. Cells of such lines are transformed with exogenous genetic material of interest and then used to provide chimeric ungulates which have germ cells comprising the exogenous genetic material. The chimeric ungulates are bred to provide transgenic ungulates. The transgenic animals of the invention may show improved qualities and can be used to provide human proteins or peptide hormones or can be used as xenograft donors. | ||||||
| 197 | Hoof protection agent and hoof protection composition | JP2002303673 | 2002-10-18 | JP2003199469A | 2003-07-15 | SANO TAKASHI; NARITA HIROKAZU |
| PROBLEM TO BE SOLVED: To provide a hoof-protection agent for ungulates composed mainly of a modified polyester, and provide a protection composition compounded with the agent. SOLUTION: The agent for the protection of the hoof of an ungulate is composed of a polymer produced by partially esterifying a polymer of acrylic acid, methacrylic acid or their mixture with a 4-8C alkyl group or a composition produced by dissolving the polymer in an alcohol. The polymer produced by partially esterifying a polymer of acrylic acid, methacrylic acid or their mixture with a 4-8C alkyl group and the composition containing the polymer are effective for remarkably increasing the strength of the hoof and have a moderate moisture permeability and, accordingly, these materials are useful for the protection of the hoof of ungulates. COPYRIGHT: (C)2003,JPO | ||||||
| 198 | VACCINE AGAINST PAPILLOMATOUS DIGITAL DERMATITIS (PDD) | PCT/US9926537 | 1999-11-09 | WO0027429A3 | 2000-11-23 | WALKER RICHARD L; READ DERYCK H; HIRD DAVID W; LEFEBVRE RANCE B; BERRY STEVEN L; CULLOR JAMES S; LEFLER HANK M |
| This invention relates to the diagnosis and prevention of ungulate diseases caused by the spirochete bacteria Treponema. The invention specifically relates to isolated cultures of this spirochete and isolated nucleic acids and proteins. | ||||||
| 199 | Grazing method for controlling and/or eradicating noxious plants including invasive plant species | US11304476 | 2005-12-14 | US20060112889A1 | 2006-06-01 | Mark Robbins |
| The present invention is a method of controlling noxious plant species. The method comprises identifying a target area in a foraging area, selecting a treatment period, selecting an ungulate specie, providing an animal feed supplement at a first deployment location in the target area, and introducing the selected ungulate specie to the animal feed supplement in the target area during the treatment period. The target is considered such because it includes a noxious plant specie. During the treatment period, the selected ungulate specie will interact with the noxious plant specie in the target area. For example, the ungulates interact with the noxious plant specie by eating the noxious plant specie and/or by trampling the noxious plant specie. The animal feed supplement is highly-palatable, portable, self-limiting, attracts the ungulate specie to the target area, and increases the length of stay of the ungulate specie in the target area. | ||||||
| 200 | Preconditioning a wildlife foraging area | US10626293 | 2003-07-24 | US07028639B2 | 2006-04-18 | Mark A. Robbins |
| The present invention, in one embodiment, is a method of using a plurality of domestic ungulates to precondition a foraging area to enhance the attractiveness of the foraging area to a plurality of wild ungulates. The method comprises selecting the foraging area to be preconditioned, selecting a target period, selecting a preconditioning period, and providing at least one highly palatable, portable, self-limiting, animal feed supplement in the foraging area during the preconditioning period. The target period is when the plurality of wild ungulates uses the foraging area once it has been preconditioned. The preconditioning period is when the plurality of domesticated ungulates preconditions (i.e., forages) the foraging area for use by the wild ungulates during the target period. The highly palatable, portable, self-limiting, animal feed supplement attracts the plurality of domesticated ungulates to the foraging area and increases the length of stay of the plurality of domesticated ungulates in the foraging area. | ||||||
QQ群二维码
意见反馈
意见反馈